Multiple sclerosis (MS) is a chronic inflammatory condition not commonly associated with cancer. Although since 1993 with the introduction of disease modifying therapies (DMTs), changing the natural history of the disease, cancer risk appears associated with some of these new therapies. We present the most common risks associated with each DMTs.
No takes yet. Share an insight, caveat, or question.
Gonçalves MVM (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: